Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism

Pierre Bouloux, David W. Warne, Ernest Loumaye

Open source

DOI
10.1016/s0015-0282(01)02973-9
Published
2002-02
Container
Fertility and Sterility
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0015-0282-01-02973-9,
  title = {Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism},
  author = {Pierre Bouloux and David W. Warne and Ernest Loumaye},
  year = {2002},
  journal = {Fertility and Sterility},
  doi = {10.1016/s0015-0282(01)02973-9},
  url = {https://doi.org/10.1016/s0015-0282(01)02973-9}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism
AU  - Pierre Bouloux
AU  - David W. Warne
AU  - Ernest Loumaye
PY  - 2002
JO  - Fertility and Sterility
DO  - 10.1016/s0015-0282(01)02973-9
UR  - https://doi.org/10.1016/s0015-0282(01)02973-9
ER  - 

APA

Bouloux, P., Warne, D. W., & Loumaye, E. (2002). Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertility and Sterility. https://doi.org/10.1016/s0015-0282(01)02973-9

Source records